Cannabinoid Regulation of Murine Vaginal Secretion

Area of Science:

• Reproductive biology
• Endocrinology
• Pharmacology

Background:

• Vaginal moisture is crucial for reproductive health and comfort, influenced by exocrine secretion and exudation.
• Exocrine gland disorders, like Sjögren's Syndrome, cause dryness affecting eyes, mouth, and vagina.
• Cannabis use is linked to dry eye and mouth; some women report vaginal dryness, suggesting cannabinoid system involvement.

Purpose of the Study:

• To investigate the role of the cannabinoid signaling system, specifically CB1 receptors, in regulating vaginal moisture in a murine model.
• To determine the effects of acute and chronic activation of CB1 receptors on basal and pheromone-stimulated vaginal secretion.

Main Methods:

• Utilized a murine model to measure basal and pheromone-stimulated vaginal moisture.
• Administered the CB1 receptor agonist CP55940 acutely and chronically.
• Assessed the effects of CP55940 and Δ⁹-tetrahydrocannabinol (THC) on vaginal moisture levels.

Main Results:

• Acute CP55940 administration did not alter baseline vaginal moisture but inhibited pheromone-stimulated secretion via a local effect.
• Chronic intermittent CP55940 administration reduced basal vaginal moisture and revealed potentiating effects, indicating multiple sites of action.
• Δ⁹-tetrahydrocannabinol (THC), a partial CB1 agonist, showed no acute or chronic effects on vaginal moisture.

Conclusions:

• Acute CB1 receptor activation in mice does not reduce vaginal moisture but can prevent stimulated secretion.
• Chronic intermittent CB1 receptor activation leads to reduced baseline vaginal moisture.
• Further research is needed to ascertain the relevance of these findings to human vaginal physiology.